Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Bi Hong Gang | 23-Dec-25 | INED | |||
| 08-Oct-24 | INED, MbCC, MbNC | ||||
| Chen Chen | 08-Oct-24 | Sup | |||
| Chen Qi Feng | 23-Dec-25 | INED | |||
| 08-Oct-24 | INED, ChAC, MbAC, MbNC | ||||
| Henry Qixiang Li | 01-Jan-22 | CEO, CSciO, GM, ED | |||
| Ke Hang | 13-Dec-22 | Sup, ChSup | |||
| Li Jian | 04-Mar-24 | Non-executive Director | |||
| Li Jian | 04-Mar-24 | NED, MbCC | |||
| Li Kin Wai | 01-Jun-25 | J-CoSec, AuRep | |||
| Li Qi Xiang Henry | 01-Mar-24 | ED | |||
| Liu Min | 11-Dec-22 | ED | |||
| Liu Min | 11-Dec-22 | COO, V-GM, ED | |||
| Sun Peng | 08-Oct-24 | Sup | |||
| Weimin Tang | 01-Sep-25 | CBO | |||
| Wong Sai Hung | 23-Dec-25 | INED | |||
| 08-Oct-24 | INED, MbAC, ChCC, MbCC | ||||
| Xiao Jieyu | 08-Feb-26 | ED, CFO, BrdSec | |||
| 01-Mar-24 | MbNC | ||||
| 01-Mar-24 | 08-Feb-26 | NED, MbAC | Due to work adjustment, Ms. Xiao has been re-designated from a non-executive Director to an executive Director. Xiao has been appointed as the chief financial officer and secretary of the Board. | ||
| Zhang Fa Ming | 01-Mar-24 | ED, Ch, AuRep, ChNC, MbNC | |||
| Zhang Hui | 01-Aug-24 | 08-Feb-26 | J-CoSec, BrdSec, V-GM | Mr. Zhang has resigned to pursue his other personal and career developments. | |
| 08-Feb-26 | CFO | Mr. Zhang has resigned to pursue his other personal and career developments. | |||
| Zhang Lei | 01-Jan-22 | CMedO, V-GM | |||
| Zhang Qiong Guang | 08-Feb-26 | MbAC | |||
| 23-Dec-25 | INED | ||||
| 08-Oct-24 | INED, MbNC |